Generics Bulletin

Who’s Hired? Ananth Returns To Teva As New API Chief

As Strides Switches COO And Civica Rx Announces Sterile Injectables Site Manager

08 Nov 2023

Teva has announced that R. Ananthanarayanan – known as Ananth – is to rejoin the company as CEO of its active pharmaceutical ingredients business after taking leading roles at Cipla and Strides in recent years. Meanwhile, Strides has disclosed a change of chief operating officer coming next year, while Civica Rx has named a manager for its sterile injectables operations.

Welcome back spelled out in tiles — R. Ananthanarayanan is returning to Teva • Source: Shutterstock

Teva has announced that its former active pharmaceutical ingredient and biologics operations chief of several years ago, R. Ananthanarayanan, is to rejoin the company as CEO of its Teva API business from 27 November. He will be based out of Teva’s US headquarters in Parsippany, New Jersey.

Ananthanarayanan – also known as Ananth – has served in multiple high-profile roles since leading the former Teva API and...